Novavax execs cash out on stock buoyed by Covid-19 vaccine work

The sales follow recent developments in Novavax’s Covid-19 vaccine program that propelled its share price this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.